Jan 07, 2021 / 02:00PM GMT
David A. Giljohann - Exicure, Inc. - CEO, Interim Principal Financial Officer, Corporate Secretary & Director
Hi, everybody, and welcome to Exicure's R&D Day. My name is David Giljohann, I'm the CEO of Exicure. And on behalf of the entire Exicure team and our guests today, thank you for joining us as we discuss how Exicure is building a leading platform in neurology and working to bring that platform into patients as fast as possible.
A couple of notes as we get started. We are a publicly traded company out of the ticker symbol XCUR. As such, we refer to -- you to our SEC guidance regarding forward-looking statements and nonsolicitation.
We have a dynamic group of speakers ready to go for today. In addition to myself, we have Matthias Schroff, our Chief Operating Officer; Doug Feltner, our Chief Medical Officer; Susan Perlman, a Clinical Professor of Neurology at UCLA; Jen Farmer from FARA; and our program managers for Neuro, Grant Corbett and Bart Anderson.
We're very pleased today to have Dr. Susan Perlman joining us. Susan Perlman is a Clinical Professor of Neurology
Exicure Inc R&D Day - Virtual Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers